Corentec Co

Corentec Co Stock-Based Compensation

The Stock-Based Compensation (SBC) of Corentec Co (104540.KQ) as of Nov 7, 2026 is 69.89 M KRW. In the previous year, Stock-Based Compensation (SBC) was 278.69 M KRW — a change of -74.92% (lower).

Stock-Based Compensation

69.89 MKRW

YoY

-74.92%

Last updated:

Stock-Based Compensation (SBC) of Corentec Co is 2023 69.89 M KRW. Stock-Based Compensation (SBC) of Corentec Co was 2022 278.69 M KRW. It decreases by -74.92% lower compared to the previous year.

The Corentec Co Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
65.80 M KRW
Jan 1, 2020
76.71 M KRW
Jan 1, 2021
334.27 M KRW
Jan 1, 2022
278.69 M KRW
Jan 1, 2023
69.89 M KRW
The Corentec Co Stock-Based Compensation history
YEARStock-Based CompensationYoY
69.89 MKRW-74.92%
278.69 MKRW-16.63%
334.27 MKRW+335.78%
76.71 MKRW+16.57%
65.80 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Stock-Based Compensation (SBC) of Corentec Co is 69.89 M KRW in 2023.

Stock-Based Compensation (SBC) of Corentec Co changed from 278.69 M KRW to 69.89 M KRW, representing a -74.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co